An Exploratory Study of DNA and Chromosomal Damage in UK Nuclear Medicine Technologists
Irene Mbutu-Austin +6 more
openalex +1 more source
Regulatory and organisational barriers to non-commercial clinical trials in European nuclear medicine: Results from an EANM survey [PDF]
Matteo Bauckneht +5 more
openalex +1 more source
Frequency and Phenotype of Coexisting Aquaporin‐4 and Autoimmune Encephalitis Autoantibodies
ABSTRACT Among 9457 aquaporin‐4 (AQP4) immunoglobulin G‐positive patients, 2071 underwent autoimmune encephalitis antibody testing and 85 (4%) had coexisting antibodies, most commonly cerebrospinal fluid glial fibrillary acidic protein‐IgG and N‐methyl‐D‐aspartate receptor‐IgG, or serum high‐titer GAD65‐IgG.
Laura Cacciaguerra +25 more
wiley +1 more source
Recurrence: A Patient’s Perspective on How Nuclear Medicine Creates Hope Through Clarity [PDF]
Michael Crosby
openalex +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
THE IMPACT OF SPECT/CT HYBRID IMAGING ON ENHANCING DIAGNOSTIC ACCURACY OF PARATHYROID ADENOMA USING 99MTC-MIBI SCAN IN NUCLEAR MEDICINE DEPARTMENT OF KOSOVO [PDF]
Ismet Bajrami
openalex +1 more source
ABSTRACT Background Dysregulated lipid metabolism, which can affect remyelination and neural repair, has not been extensively investigated in progressive multiple sclerosis (PMS). The goal was to examine whether dysregulated cholesterol metabolism was associated with disability in PMS. Methods The study sample comprised 53 Severe PMS patients (Expanded
Taylor R. Wicks +8 more
wiley +1 more source
Corrigendum to “Nationwide phantom evaluation of real-world amyloid PET imaging in Japan under the Japanese society of nuclear medicine qualification program required for reimbursement” [The EANM J 4 September (2026) 100239] [PDF]
Yasuhiko Ikari +10 more
openalex +1 more source
The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta +11 more
wiley +1 more source

